Comparison

JH-RE-06

Item no. MOLN-M22367-1g
Manufacturer Molnova
CASRN 1361227-90-8
Amount 1 g
Quantity options 100 mg 10 mg 1 g 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Purity >98% (HPLC)
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Molecular Weight
468, 72
Brief description
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
Note
Research use only, not for human use.
Stability
≥ 2 years
Receptor
REV1-REV7

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close